NEWS: Sanders Responds to FTC’s Efforts to Target ‘Junk’ Ozempic Patents
WASHINGTON, April 30 — Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, today released the following statement after Federal Trade Commission (FTC) Chair Lina Khan announced that the FTC is taking action against the bogus patents Novo Nordisk filed to keep the outrageous price of Ozempic artificially high: Let me commend the Federal